Elizabeth Hickin

Elizabeth Hickin is an accomplished professional in investor relations and communications, currently serving as Vice President of Investor Relations at Zentalis Pharmaceuticals since April 2024. Previous roles include Senior Director and Director of Investor Relations at 2seventy bio from November 2021 to April 2024, and Director of Investor Relations at bluebird bio from April 2016 to November 2021. Elizabeth also held positions at Takeda Oncology, Waggener Edstrom, LaVoie Group, Lois Paul & Partners, and UBS Investment Bank, demonstrating a diverse background in public relations and corporate communications. Elizabeth earned a Bachelor of Arts in English from Georgetown University and has also studied at the University of Galway.